Condensed Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 23,738,053	$ 116,013
Total current assets	23,738,053	116,013
Total assets	23,738,053	116,013
Current liabilities:
Accounts payable and accrued expenses	1,176,226	96,798
Accrued compensation	390,981	417,611
Warrant liability		56,000
Current portion of long-term debt, net of debt discount	1,069,802
Total current liabilities	2,637,009	570,409
Long-term debt, net of current portion	1,878,436	979,792
Total liabilities	4,515,445	1,550,201
Commitments and contingencies
Series A convertible preferred stock and preferred stock, value
Stockholders' equity (deficit):
Common stock, $0.0001 par value; authorized shares - 50,000,000 at September 30, 2013 and 20,000,000 at December 31, 2012; issued and outstanding shares - 5,781,752 at September 30, 2013 and 1,242,750 at December 31, 2012	578	124
Additional paid-in capital	40,296,800	195,525
Deficit accumulated during the development stage	(21,074,770)	(19,855,003)
Total stockholders' equity (deficit)	19,222,608	(19,659,354)
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	23,738,053	116,013
Series A convertible preferred stock [Member]
Current liabilities:
Series A convertible preferred stock and preferred stock, value		$ 18,225,166